These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2860681)

  • 21. The EEG in obsessive-compulsive disorder.
    Jenike MA; Brotman AW
    J Clin Psychiatry; 1984 Mar; 45(3):122-4. PubMed ID: 6698944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Obsessive-compulsive symptoms in schizophrenia during treatment with clozapine and conventional antipsychotic drugs].
    Galvez-Buccollini JA; Fiestas F; Herrera P; Vega-Dienstmaier JM; Guimas B; Mazzotti G
    Actas Esp Psiquiatr; 2004; 32(4):211-5. PubMed ID: 15232749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent developments in the use of antidepressant and anxiolytic medications.
    Simeon JG; Ferguson HB
    Psychiatr Clin North Am; 1985 Dec; 8(4):893-907. PubMed ID: 2867535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral activation in children and adolescents with obsessive-compulsive disorder before and after treatment: a functional MRI study.
    Lázaro L; Caldú X; Junqué C; Bargalló N; Andrés S; Morer A; Castro-Fornieles J
    J Psychiatr Res; 2008 Oct; 42(13):1051-9. PubMed ID: 18261744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current status of obsessional compulsive disorders: theories, epidemiology and treatment].
    Bourgeois M; Peyre F; Verdoux H
    Ann Med Psychol (Paris); 1989 Sep; 147(7):768-75. PubMed ID: 2694888
    [No Abstract]   [Full Text] [Related]  

  • 26. [Practice guidelines--therapy of anxiety and compulsive disorders. Recommendations for therapy of anxiety and compulsive disorders of the Drug Commission of the German Medical Society].
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):241-4. PubMed ID: 10802900
    [No Abstract]   [Full Text] [Related]  

  • 27. [Is it time for revision of the section on obsessive-compulsive disorder in the Guideline on Anxiety Disorders?].
    van Ingen Schenau WJ; Wisman PW
    Tijdschr Psychiatr; 2007; 49(5):315-25. PubMed ID: 17492582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiological evidence for cortical abnormalities in obsessive-compulsive disorder - a replication study using auditory event-related P300 subcomponents.
    Gohle D; Juckel G; Mavrogiorgou P; Pogarell O; Mulert C; Rujescu D; Giegling I; Zaudig M; Hegerl U
    J Psychiatr Res; 2008 Mar; 42(4):297-303. PubMed ID: 17328913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials.
    Skapinakis P; Papatheodorou T; Mavreas V
    Eur Neuropsychopharmacol; 2007 Jan; 17(2):79-93. PubMed ID: 16904298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative syndrome in schizophrenia: strategies for long-term management.
    Andreasen NC
    Adv Biochem Psychopharmacol; 1985; 40():1-7. PubMed ID: 2862761
    [No Abstract]   [Full Text] [Related]  

  • 31. Deep brain stimulation in obsessive-compulsive disorder.
    Denys D; Mantione M
    Prog Brain Res; 2009; 175():419-27. PubMed ID: 19660670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-androgenic treatment of obsessive-compulsive disorder: an open-label clinical trial of the long-acting gonadotropin-releasing hormone analogue triptorelin.
    Eriksson T
    Int Clin Psychopharmacol; 2007 Jan; 22(1):57-61. PubMed ID: 17159461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep brain stimulation for obsessive-compulsive disorder: using functional magnetic resonance imaging and electrophysiological techniques: technical case report.
    Baker KB; Kopell BH; Malone D; Horenstein C; Lowe M; Phillips MD; Rezai AR
    Neurosurgery; 2007 Nov; 61(5 Suppl 2):E367-8; discussion E368. PubMed ID: 18091226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Attempt at an application in psychiatry of the negative contingent variation].
    Dongier M; Bostem F
    Acta Neurol Psychiatr Belg; 1967 Aug; 67(8):640-5. PubMed ID: 4964898
    [No Abstract]   [Full Text] [Related]  

  • 35. Selective sound intolerance and emotional distress: what every clinician should hear.
    Hadjipavlou G; Baer S; Lau A; Howard A
    Psychosom Med; 2008 Jul; 70(6):739-40. PubMed ID: 18596245
    [No Abstract]   [Full Text] [Related]  

  • 36. [Course and prognosis of obsessive-compulsive disorders].
    Knölker U
    MMW Fortschr Med; 2004 Mar; 146(12):34-5. PubMed ID: 15357501
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnosing and managing psychotic and mood disorders.
    Nasrallah HA; Black DW; Goldberg JF; Muzina DJ; Pariser SF
    Ann Clin Psychiatry; 2008; 20 Suppl 1():S1-28; quiz S29-30. PubMed ID: 19034748
    [No Abstract]   [Full Text] [Related]  

  • 38. Anxious depression.
    Lydiard RB; Brawman-Mintzer O
    J Clin Psychiatry; 1998; 59 Suppl 18():10-7. PubMed ID: 9840193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults.
    Castaneda AE; Tuulio-Henriksson A; Marttunen M; Suvisaari J; Lönnqvist J
    J Affect Disord; 2008 Feb; 106(1-2):1-27. PubMed ID: 17707915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Punding in Parkinson's disease.
    O'Sullivan SS; Evans AH; Lees AJ
    Pract Neurol; 2007 Nov; 7(6):397-9. PubMed ID: 18024780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.